Metformin Hydrochloride

Zydus Lifesciences gets USFDA final approval to market diabetes drug

Zydus Lifesciences Ltd on Monday said it has received final approval from the US health regulator to market its generic version of Empagliflozin and Metformin Hydrochloride tablets